Clearance of beta-amyloid in the brain

Current Medicinal Chemistry

Volumn 21, Issue 35, 2014, Pages 4085-4090

  Ueno, Masaki ^a   Chiba, Yoichi ^a   Matsumoto, Koichi ^a   Nakagawa, Toshitaka ^b   Miyanaka, Hiroshi ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Amyloid ; Blood brain barrier; CSF; ISF; Perivascular drainage

Indexed keywords

AMYLOID BETA PROTEIN; CARRIER PROTEIN; PEPTIDE HYDROLASE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN LEVEL; CELL LEVEL; CLEARANCE; ENZYME DEGRADATION; EXCRETION; EXTRACELLULAR SPACE; HUMAN; INTERSTITIAL FLUID; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN TRANSPORT; SOLUTE; ALZHEIMER DISEASE; BRAIN; CEREBROSPINAL FLUID; EXTRACELLULAR FLUID; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOOD-BRAIN BARRIER; BRAIN; EXTRACELLULAR FLUID; HUMANS; MEMBRANE TRANSPORT PROTEINS; PEPTIDE HYDROLASES;

EID: 84929094945     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666141011194256     Document Type: Article

References (68)

1. Broadwell, R. D.; Sofroniew, M. V. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp. Neurol., 1993, 120(2), 245-263.
2. Ueno, M.; Akiguchi, I.; Hosokawa, M.; Yagi, H.; Takemura, M.; Kimura, J.; Takeda, T. Accumulation of blood-borne horseradish peroxidase in medial portions of the mouse hippocampus. Acta Neurol. Scand., 1994, 90(6), 400-404.
3. Ueno, M.; Akiguchi, I.; Hosokawa, M.; Kotani, H.; Kanenishi, K.; Sakamoto, H. Blood-brain barrier permeability in the periventricular areas of the normal mouse brain. Acta Neuropathol., 2000, 99(4), 385-392.
4. Ohtsuki, S.; Terasaki, T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res., 2007, 24(9), 1745-1758.
5. Zlokovic, B. V. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics, 2008, 5(3), 409-414.
6. Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron, 2008, 57(2), 178-201.
7. Mawuenyega, K. G.; Sigurdson, W.; Ovod, V.; Munsell, L.; Kasten, T.; Morris, J. C.; Yarasheski, K. E.; Bateman, R. J. Decreased clearance of CNS β-amyloid in Alzheimer's disease. Science, 2010, 330(6012), 1774.
8. Bradbury, M. W.; Cserr, H. F.; Westrop, R. J. Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am. J. Physiol., 1981, 240(4), F329-F336.
9. Carare, R. O.; Bernardes-Silva, M.; Newman, T. A.; Page, A. M.; Nicoll, J. A. R.; Perry, V. H.; Weller, R. O. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries. Significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol. Appl. Neurobiol., 2008, 34(2), 131-144.
10. Weller, R. O.; Djuanda, E.; Yow, H.-Y.; Carare, R. O. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol., 2009, 117(1), 1-14.
11. Carare, R. O.; Hawkes, C. A.; Jeffrey, M.; Kalaria, R. N.; Weller, R. O. Cerebral amyloid angiopathy, prion angiopathy, CADASIL and spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol. Appl. Neurobiol., 2013, 39(6), 593-611.
12. Bechmann, I.; Kwidzinski, E.; Kovac, A. D.; Simburger, E.; Horvath, T.; Gimsa, U.; Dimagl, U.; Priller, J.; Nitsch, R. Turnover of rat brain perivascular cells. Exp. Neurol., 2001, 168(2), 242-249.
13. Rennels, M. L.; Gregory, T. F.; Blaumanis, O. R.; Fujimoto, K.; Grady, P. A. Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res., 1985, 326(1), 47-63.
14. Hutchings, M.; Weller, R. O. Anatomical relationships of the pia mater to cerebral blood vessels in man. J. Neurosurg., 1986, 65(3), 316-325.
15. Alcolado, R.; Weller, R. O.; Parrish, E. P.; Garrod, D. The cranial arachnoid and pia mater in man: anatomical and ultrastructural observations. Neuropathol. Appl. Neurobiol., 1988, 14(1), 1-17.
16. Szentistvanyi, I.; Patlak, C. S.; Ellis, R. A.; Cserr, H. F. Drainage of interstitial fluid from different regions of rat brain. Am. J. Physiol., 1984, 246(6), F835-F844.
17. Schley, D.; Carare-Nnadi, R.; Please, C. P.; Perry, V. H.; Weller, R. O. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J. Theor. Biol., 2006, 238(4), 962-974.
18. Wang, P.; Olbricht, W. L. Fluid mechanics in the perivascular space. J. Theor. Biol., 2011, 274(4), 52-57.
19. Gosselet, F.; Saint-Pol, J.; Candela, P.; Fenart, L. Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier. Curr. Alzheimer Res., 2013, 10(10), 1015-1033.
20. Ito, S.; Matsumiya, K.; Ohtsuki, S.; Kamiie, J.; Terasaki, T. Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-β peptide (1-40) in mouse brain. J. Cereb. Blood Flow Metab., 2013, 33(11), 1770-1777.
21. Wildsmith, K. R.; Holley, M.; Savage, J.; Skerrett, R.; Landreth, G. E. Evidence for impaired amyloid β clearance in Alzheimer's disease. Alzheimer's Res. Ther., 2013, 5(4), 33.
22. Potter, R.; Patterson, B. W.; Elbert, D. L.; Ovod, V.; Kasten, T.; Sigurdson, W.; Mawuenyega, K.; Blazey, T.; Goate, A.; Chott, R.; Yarasheski, K. E.; Holtzman, D. M.; Morris, J. C.; Benzinger, T. L.; Bateman, R. J. Increased in vivo amyloid-β42 production, exchange, and irreversible loss in presenilin mutations carriers. Sci. Transl. Med., 2013, 5(189), 189ra77.
23. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 2001, 81(2), 741-766.
24. Herzig, M. C.; Van Nostrand, W. E.; Jucker, M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol., 2006, 16(1), 40-54.
25. Kalaria, R. N.; Premkumar, D. R.; Pax, A. B.; Cohen, D. L.; Lieberburg, I. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. Brain Res. Mol. Brain Res., 1996, 35(1-2), 58-68.
26. Frackowiak, J.; Potempska, A.; LeVine, H.; Haske, T.; Dickson, D.; Mazur-Kolecka, B. Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. J. Neuropathol. Exp. Neurol., 2005, 64(1), 82-90.
27. Miners, J. S.; Van Helmond, Z.; Chalmers, K.; Wilcock, G.; Love, S.; Kehoe, P. G. Decreased expression and activity of neprilysin in Alzheimer's disease are associated with cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol., 2006, 65(10), 1012-1021.
28. Fukami, S.; Watanabe, K.; Iwata, N.; Haraoka, J.; Lu, B.; Gerard, N. P.; Gerard, C.; Fraser, P.; Westaway, D.; St. George-Hyslop, P.; Saido, T. C. A beta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci. Res., 2002, 43(1), 39-56.
29. Leissring, M. A.; Farris, W.; Chang, A. Y.; Walsh, D. M.; Wu, X.; Sun, X.; Frosch, M. P.; Selkoe, D. J. Enhanced proteolysis of betaamyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron, 2003, 40(6), 1087-1093.
30. Stargardt, A.; Gillis, J.; Kamphuis, W.; Wiemhoefer, A.; Kooijman, L.; Raspe, M.; Benckhuijsen, W.; Drijfhout, J. W.; Hol, E. M.; Reits, E. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models. Aging Cell, 2013, 12(3), 499-507.
31. Donahue, J. E.; Flaherty, S. L.; Johanson, C. E.; Duncan, III J. A.; Silverberg, G. D.; Miller, M. C.; Tavares, R.; Yang, W.; Wu, Q.; Sabo, E.; Hovanesian, V.; Stopa, E. Gβ RAGE, LRP-1, and amyloidbeta protein in Alzheimer's disease. Acta Neuropathol., 2006, 112(4), 405-415.
32. Zlokovic, B. V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci., 2005, 28(4), 202-208.
33. Deane, R.; Du, Y. S.; Submamaryan, R. K.; LaRue, B.; Jovanovic, S.; Hogg, E.; Welch, D.; Manness, L.; Lin, C.; Yu, J.; Zhu, H.; Ghiso, J.; Frangione, B.; Stern, A.; Schmidt, A. M.; Armstrong, D. L.; Arnold, B.; Liliensiek, B.; Nawroth, P.; Hofman, F.; Kindy, M.; Stern, D.; Zlokovic, B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med., 2003, 9(7), 907-913.
34. Deane, R.; Wu, Z.; Zlokovic, B. V. RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke, 2004, 35(11), 2628-2631.
35. Zlokovic, B. V.; Martel, C. L.; Matsubara, E.; McComb, J. G.; Zheng, G.; McCluskey, R. T.; Frangione, B., Ghiso, J. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. U. S. A., 1996, 93(9), 4229-4234.
36. Zlokovic, B. V. Cleaning amyloid through the blood-brain barrier. J. Neurochem., 2004, 89(4), 807-811.
37. Herz, J.; Marschang, P. Coaxing the LDL receptor family into the fold. Cell, 2003, 112(3), 289-292.
38. Shibata, M.; Yamada, S.; Kumar, S. R.; Calero, M.; Bading, J.; Frangione, B.; Holtzman, D. M.; Miller, C. A.; Strickland, D. K.; Ghiso, J.; Zlokovic, B. V. Clearance of Alzheimer's amyloid beta (1-40) peptide from brain by LDL-receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest., 2000, 106(12), 1489-1499.
39. Fujiyoshi, M.; Tachikawa, M.; Ohtsuki, S.; Ito, S.; Uchida, Y.; Akanuma, S.; Kamiie, J.; Hashimoto, T.; Hosoya, K.; Iwatsubo, T.; Terasaki, T. Amyloid-β peptide (1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier. J. Neurochem., 2011, 118(3), 407-415.
40. Ito, S.; Ueno, T.; Ohtsuki, S.; Terasaki, T. Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-β peptide (1-40) in mouse: involvement of an LRP-1-independent pathway. J. Neurochem., 2010, 113(5), 1356-1363.
41. Cirrito, J. R.; Deane, R.; Fagan, A. M.; Spinner, M. L.; Parsadanian, M.; Finn, M. B.; Jiang H.; Prior, J. L.; Sagare, A.; Bales, K. R.; Paul, S. M.; Zlokovic, B. V.; Piwnica-Worms, D.; Holtzman, D. M. Pglycoprotein deficiency at the blood-brain barrier increases amyloidbeta deposition in an Alzheimer's disease mouse models. J. Clin. Invest., 2005, 115(11), 3285-3290.
42. Ling, V. P-glycoprotein: its role in drug resistance. Am. J. Med., 1995, 99 (6 A), 31S-34S.
43. Bodo, A.; Bakos, E.; Szeri, F.; Varadi, A.; Sarkadi, B. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol. Lett., 2003, 140-141, 133-143.
44. Fromm, M. F. Importance of P-glycoprotein for drug disposition in humans. Eur. J. Clin. Invest., 2003, 33(Suppl 2), 6-9.
45. Schinkel, A. H.; Jonker, J. W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev., 2003, 55(1), 3-29.
46. Schinkel, A. H.; Smit, J. J.; Van Tellingen, O.; Beijnen, J. H.; Wagennaar, E. W.; Van Deemter, L.; Mol, C. A.; Van Der Valk, M. A.; Robanus-Maandag, E. C.; Riele, H. P.; Berns, A. J. M.; Borst, P. Disruption of the mouse mdr1a p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 1994, 77(4), 491-502.
47. Vogelgesang, S.; Warzok, R. W.; Cascorbi, I.; Kunert-Keil, C.; Schroeder, E.; Kroemer, H. K.; Siegmund, W.; Walker, L. C.; Pahnke, J. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. Curr. Alzheimer Res., 2004, 1(2), 121-125.
48. Weller, R. O.; Massery, A.; Newman, T. A.; Hutchings, M.; Kuo, Y. M.; Roher, A. E. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol., 1998, 153(3), 725-733.
49. Deane, R.; Sagare, A.; Hamm, K.; Parisi, M.; Lane, S.; Finn, M. B.; Holtzman D. M.; Zlokovic, B. V. apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain. J. Clin. Invest., 2008, 118(12), 4002-4013.
50. Castellano, J. M.; Kim, J.; Stewart, F. R.; Jiang, H.; DeMattos, R. B.; Patterson, B. W.; Fagan, A. M.; Morris, J. C.; Mawuenyega, K. G.; Cruchaga, C.; Goate, A. M.; Bales, K. R.; Paul, S. M.; Bateman, R. J.; Holtzman, D. M. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci. Transl. Med., 2011, 3(89), 89ra57.
51. Krohn, M.; Lange, C.; Hoftichter, J.; Scheffler, K.; Stenzel, J.; Steffen, J.; Schumacher, T.; Bruning, T.; Plath, A.-S.; Alfen, F.; Schmidt, A.; Winter, F.; Rateitschank, K.; Wree, A.; Gsponer, J.; Walker, L. C.; Pahnke, J. Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice. J. Clin. Invest., 2011, 121(10), 3924-3931.
52. Castellano, J. M.; Deane, R.; Gottesdiener, A. J.; Verghese, P. B.; Stewart, F. R.; West, T.; Paoletti, A. C.; Kasper, T. R.; DeMattos, R. B.; Zlokovic, B. V.; Holtzman, D. M. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(38), 15502-15507.
53. Do, T. M.; Noel-Hudson, M.-S.; Ribes, S.; Besengez, C.; Smimova, M.; Cistemino, S.; Buyse, M.; Calon, F.; Chimin, G.; Chacun, H.; Schermann, J.-M.; Farinotti, R.; Bourasset, F. ABCG2- and ABCG-4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. J. Alzheimer's Dis., 2012, 30(1), 155-166.
54. Tai, L. M.; Loughlin, A. J.; Male, D. K.; Romero, I. A. P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta. J. Cereb. Blood Flow Metab., 2009, 29(6), 1079-1083.
55. Coraci, I. S.; Husemann, J.; Berman, J. W.; Hulette, C.; Dufour, J. H.; Campanella, G. K.; Luster, A. D.; Silverstein, S. C.; El-Khoury, J. B. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol., 2002, 160(1), 101-112.
56. Moore, K. J.; El-Khoury, J.; Medeiros, L. A.; Terada, K.; Geula, C.; Luster, A. D.; Freeman, M. W. A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid. J. Biol. Chem., 2002, 277(49), 47373-47379.
57. Park, L.; Wang, G.; Zhou P.; Zhou J.; Pitstick, R.; Previti, M. L.; Younkin, L.; Younkin, S. G.; Van Nostrand, W. E.; Cho, S.; Anrather, J.; Carlson, G. A.; Iadecola, C. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β. Proc. Natl. Acad. Sci. U. S. A., 2011, 108(102), 5063-5068.
58. Preston, S. D.; Steart, P. V.; Wilkinson, A.; Nicoll, J. A. R.; Weller, R. O. Capillary and arterial amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol. Appl. Neurobiol., 2003, 29(2), 106-117.
59. Bell, R. D.; Sagare, A. P.; Friedman, A. E.; Bedi, G. S.; Holtzman, D. M.; Deane, R.; Zlokovic, B. V. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab., 2007, 27(5), 909-918.
60. Wilhelmus, M. M.; Otte-Holler, I.; Van Triel, J. J.; Veerhuis, R.; Maat-Schieman, M. L.; Bu, G.; De Waal, R. M.; Verbeek, M. M. Lipoprotein receptor-related protein-1 mediates amyloid-β-mediated cell death of cerebrovascular cells. Am. J. Pathol., 2007, 171(6), 1989-1999.
61. Kenekiyo, T.; Liu, C.-C.; Shinohara M.; Li, J.; Bu, G. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β. J. Neurosci., 2012, 32(46), 16458-16465.
62. Kenekiyo, T.; Crrito, J. R.; Liu, C.-C.; Shinohara, M.; Li, J.; Schuler, D. R.; Shinohara, M.; Holtzman, D. M.; Bu, G. Neuronal clearance of amyloid-β by endocytic receptor LRP1. J. Neurosci., 2013, 33(49), 19276-19283.
63. Koistinaho, M.; Lin, S.; Wu, X.; Esterman, M.; Koger, D.; Hanson, J.; Higgs, R.; Liu, F.; Malkani, S.; Bales, K. R.; Paul, S. M. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides. Nature Med., 2004, 10(7), 719-726.
64. Basak, J. M.; Verghese, P. B.; Yoon, H.; Kim, J.; Holtzman, D. M. Low-density lipoprotein receptor represents and apolipoprotein Eindependent pathway of Aβ uptake and degradation by astrocytes. J. Biol. Chem., 2012, 287(17), 13959-13971.
65. Lee, C. Y.; Landreth, G. E. The role of microglia in amyloid clearance from the AD brain. J. Neural. Transm., 2010, 117(8), 949-960.
66. Lue, L. F.; Kuo, Y. M.; Roher, A. E.; Brachova, L.; Shen, Y.; Sue, L.; Beach, T.; Kurth, J. H.; Rydel, R. E.; Roger, J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol., 1999, 155(3), 853-862.
67. Weller, R. O.; Subash, M.; Preston, S. D.; Mazanti, I.; Carare, R. O. Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol., 2008, 18(2), 253-266.
68. Hawkes, C. A.; Hartig, W.; Kacza, J.; Schliebs, R.; Weller, R. O.; Nicoll, J. A.; Carare, R. O. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol., 2011, 121(4), 431-443.